Tenet Healthcare Corporation $THC Stock Position Decreased by First Trust Advisors LP

First Trust Advisors LP cut its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 31.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 179,894 shares of the company’s stock after selling 82,896 shares during the period. First Trust Advisors LP owned approximately 0.20% of Tenet Healthcare worth $36,526,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. WCM Investment Management LLC raised its holdings in shares of Tenet Healthcare by 244.4% during the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after acquiring an additional 362,083 shares during the period. AlphaQuest LLC boosted its stake in Tenet Healthcare by 238.3% in the 3rd quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock worth $1,211,000 after purchasing an additional 4,202 shares during the period. Winnow Wealth LLC acquired a new stake in Tenet Healthcare during the 3rd quarter valued at $1,129,000. Cerity Partners LLC lifted its holdings in shares of Tenet Healthcare by 10.4% in the second quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock valued at $21,230,000 after purchasing an additional 11,395 shares in the last quarter. Finally, Savant Capital LLC boosted its position in shares of Tenet Healthcare by 27.5% in the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after buying an additional 3,647 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Down 4.2%

THC stock opened at $224.68 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The firm has a market cap of $19.54 billion, a PE ratio of 14.50, a PEG ratio of 1.15 and a beta of 1.39. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $247.21. The company has a fifty day simple moving average of $212.89 and a 200 day simple moving average of $203.65.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business’s revenue was up 8.9% compared to the same quarter last year. During the same period last year, the company earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analyst Ratings Changes

THC has been the topic of several recent analyst reports. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday, March 1st. Mizuho lifted their target price on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday. Truist Financial increased their price target on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Leerink Partners raised their price target on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. Finally, Barclays upped their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $250.56.

Insider Buying and Selling

In other news, EVP Thomas W. Arnst sold 8,000 shares of the business’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $238.85, for a total value of $1,910,800.00. Following the completion of the sale, the executive vice president directly owned 12 shares in the company, valued at approximately $2,866.20. The trade was a 99.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 42,195 shares of company stock worth $9,823,406. 0.81% of the stock is currently owned by insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.